Racial Differences in Outcomes of Osimertinib in Patients with EGFR-positive Non-Small Cell Lung Cancer in a Real World US Population
07:30am - 03:45pm EDT - March 31, 2023




Author(s):
Tags: Member Institution Outcomes and Health Services Research

Display Label Action
023-General Poster Session Download Handout